Atsushi Fukatsu
Anjo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Persistence and expansion of hypoxia detected by pimonidazole adduct immunostaining during progression of diabetic nephropathy in diabetic mice.
Journal: American journal of physiology. Renal physiology
Published: August 24, 2023
Amelioration of Murine Diabetic Nephropathy with a SGLT2 Inhibitor Is Associated with Suppressing Abnormal Expression of Hypoxia-Inducible Factors.
Journal: The American journal of pathology
Published: December 10, 2021
Sex differences in clinical outcomes in Japanese incident dialysis patients: a prospective observational multicenter study.
Journal: Clinical and experimental nephrology
Published: September 11, 2020
Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period.
Journal: Current medical research and opinion
Published: February 17, 2018
Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment.
Journal: Clinical pharmacology in drug development
Published: August 02, 2017
Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study.
Journal: Journal of diabetes investigation
Published: February 24, 2017
Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis.
Journal: Scientific reports
Published: March 21, 2016
Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models.
Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models.
Journal: Scientific reports
Published: January 18, 2016
Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials.
Journal: Clinical therapeutics
Published: September 30, 2015
Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 07, 2015
Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus.
Journal: Clinical therapeutics
Published: June 19, 2015
Last Updated: 09/26/2026